BTINYSECigarettesAlso trades as BTAFF
British American Tobacco p.l.c.
Financials through fiscal 2025, year ended Dec 31, 2025
$58.51−1.49 (-2.48%)
Close on Oct 19, 2026
British American Tobacco p.l.c. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia-Pacific | – | – | – | – | – | – | – | – | – | £4.27B | – | – |
| Americas | – | – | – | – | – | – | – | – | – | £2.87B | – | – |
| Western Europe | – | – | – | – | – | – | – | – | – | £3.87B | – | – |
| EEMEA | – | – | – | – | – | – | – | – | – | £3.75B | – | – |
| Asia Pacific and Middle East | – | – | – | – | – | – | £5.15B | £4.88B | £4.97B | £4.77B | – | – |
| AMSSA | – | – | – | – | – | – | £4.26B | £4.11B | £4.32B | £4.04B | – | – |
| Europe and North Africa | – | – | – | – | – | – | £6.09B | £6.00B | £6.11B | £5.32B | – | – |
| U.S. | – | – | – | – | – | – | £10.37B | £9.50B | £4.16B | – | – | – |
| Combustibles | – | – | – | – | – | – | £23.00B | £22.07B | £18.17B | – | – | – |
| New Categories | – | – | – | – | – | – | £1.26B | £917.00M | £385.00M | – | – | – |
| Traditional Oral | – | – | – | – | – | – | £1.08B | £941.00M | £415.00M | – | – | – |
| Other | – | – | – | – | – | – | £540.00M | £562.00M | £593.00M | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combustibles | £20.20B | £20.69B | £22.11B | £23.03B | £22.03B | £22.75B | £23.00B | – | – | – | 78.9% | -2.3% |
| New Categories | £3.62B | £3.43B | £3.35B | £2.89B | £2.05B | £1.44B | £1.26B | – | – | – | 14.1% | +5.5% |
| Traditional Oral | £1.04B | £1.09B | £1.16B | £1.21B | £1.12B | £1.16B | £1.08B | – | – | – | 4.1% | -4.5% |
| Other | £745.00M | £658.00M | £665.00M | £522.00M | £483.00M | £421.00M | £540.00M | – | – | – | 2.9% | +13.2% |
| Vapour | – | – | – | – | – | – | £401.00M | £318.00M | £168.00M | – | – | – |
| HP | – | – | – | – | – | – | £728.00M | £565.00M | £202.00M | – | – | – |
| Modern Oral | – | – | – | – | – | – | £126.00M | £34.00M | £15.00M | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All foreign countries | £25.34B | £25.61B | £27.03B | £27.43B | £25.48B | £25.59B | £25.70B | £24.31B | £19.36B | £13.86B | 99.0% | -1.1% |
| United Kingdom | £268.00M | £254.00M | £255.00M | £228.00M | £209.00M | £188.00M | £178.00M | £184.00M | £203.00M | £266.00M | 1.0% | +5.5% |
From the segment and revenue-disaggregation notes of British American Tobacco p.l.c.'s 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.